| Title:
|
ANTIDEPRESSANTS THERAPY & RISK OF SUICIDE AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDERS
|
| By: |
Maurizio Pompili, Paolo Girardi, David Lester |
| Format: |
Paperback |
| List price:
|
£61.99 |
| Our price: |
£52.69 |
| Discount: |
|
| You save:
|
£9.30 |
|
|
|
|
|
| ISBN 10: |
1617283789 |
| ISBN 13: |
9781617283789 |
| Availability: |
Usually dispatched within 1-3 weeks.
 Delivery
rates
|
| Stock: |
Currently 0 available |
| Publisher: |
NOVA SCIENCE PUBLISHERS INC |
| Pub. date: |
11 January, 2012 |
| Pages: |
56 |
| Synopsis: |
Most cases of suicide (81 per cent-95 per cent) in the general population involve psychiatric illnesses, nearly half of which (48.5 per cent) are mood disorders. Internationally, the overall average suicide rate has been rising gradually over the past half-century, with increases reported in about half of nations, mainly among men, and moderate decreases found in another half, including in Northern Europe and North America. This book reviews whether the use of antidepressants is associated with benefits in terms of completed or attempted suicide, whether the increasing use of SSRIs is associated with benefits in terms of decreased rates of suicide with the aim of generating evidence-based suggestions for clinicians. |
| Publication: |
US |
| Imprint: |
Nova Science Publishers Inc |
| Returns: |
Non-returnable |